Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.79B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$576M |
| 3 |
Microsoft
MSFT
|
+$546M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$436M |
| 5 |
JPMorgan Chase
JPM
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.48B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$765M |
| 4 |
Apple
AAPL
|
+$656M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$526M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.23% |
| 2 | Technology | 2.7% |
| 3 | Consumer Discretionary | 1.66% |
| 4 | Financials | 1.18% |
| 5 | Communication Services | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFTR
11376
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $39.1K | ﹤0.01% |
1,885
-620
| -25% | -$10.5K |
|
|
XXII
11377
PUT
22nd Century Group
XXII
$2.25M
| – | – |
0
| – | – |
|
11378
PUT
Heron Therapeutics
HRTX
$59.5M
| $39.1K | ﹤0.01% |
33,700
+20,500
| +155% | +$36.6K |
|
11379
Serina Therapeutics
SER
$65M
| $39K | ﹤0.01% |
1,241
+371
| +43% | +$7.94K |
|
11380
P3 Health Partners
PIII
$37.4M
| $38.9K | ﹤0.01% |
260
-58
| -18% | -$8.02K |
|
11381
PUT
Telos
TLS
$357M
| $38.9K | ﹤0.01% |
15,200
+3,000
| +25% | +$7.12K |
|
11382
PUT
Rackspace Technology
RXT
$874M
| $38.9K | ﹤0.01% |
+14,300
| New | +$23.6K |
|
11383
Cytosorbents Corp
CTSO
$21.9M
| $38.8K | ﹤0.01% |
10,820
-42,124
| -80% | -$133K |
|
|
SNCR
11384
DELISTED
Synchronoss Technologies
SNCR
| $38.6K | ﹤0.01% |
+4,617
| New | +$38.9K |
|
|
WKEY
11385
WISeKey
WKEY
$79.6M
| $38.2K | ﹤0.01% |
8,676
-2,377
| -22% | -$13.5K |
|
|
FAZE
11386
CALL
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $38.1K | ﹤0.01% |
77,800
-22,800
| -23% | -$11.6K |
|
11387
Mind CTI
MNDO
$20.4M
| $38.1K | ﹤0.01% |
19,478
+4,812
| +33% | +$9.38K |
|
11388
KORU Medical Systems
KRMD
$150M
| $37.9K | ﹤0.01% |
10,995
-102,617
| -90% | -$403K |
|
11389
CALL
Vista Gold
VGZ
$340M
| $37.9K | ﹤0.01% |
72,900
-4,000
| -5% | -$2.44K |
|
|
REE
11390
CALL
DELISTED
REE Automotive
REE
| $37.8K | ﹤0.01% |
3,317
| – | – |
|
|
MRDB
11391
DELISTED
MariaDB plc
MRDB
| $37.7K | ﹤0.01% |
+43,806
| New | +$48K |
|
11392
Globus Maritime Ltd
GLBS
$78.1M
| $37.6K | ﹤0.01% |
41,817
-66,137
| -61% | -$64.5K |
|
|
IDEX
11393
CALL
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $37.6K | ﹤0.01% |
4,294
-1,867
| -30% | -$14.3K |
|
|
ADIL
11394
Adial Pharmaceuticals
ADIL
$16.1M
| $37.5K | ﹤0.01% |
288
-68
| -19% | -$12.3K |
|
|
ADVM
11395
DELISTED
Adverum Biotechnologies
ADVM
| $37.4K | ﹤0.01% |
2,354
-5,967
| -72% | -$62.7K |
|
11396
Recon Technology
RCON
$865K
| $37.3K | ﹤0.01% |
+30
| New | +$42.9K |
|
|
HYPD
11397
Hyperion DeFi Inc
HYPD
$56.1M
| $37.2K | ﹤0.01% |
+196
| New | +$56.2K |
|
11398
Socket Mobile
SCKT
$6.18M
| $37K | ﹤0.01% |
25,362
+4,954
| +24% | +$7.61K |
|
11399
PUT
Cerus
CERS
$552M
| $36.9K | ﹤0.01% |
15,000
+1,700
| +13% | +$4.04K |
|
11400
CALL
American Resources Corp
AREC
$274M
| $36.8K | ﹤0.01% |
18,800
-18,100
| -49% | -$27.6K |
|
Similar funds
Jeff Yass's Q2 2023 Portfolio in Review
As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
- Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
- Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
- Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
- Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
- Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
- Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.